CLINICAL_TRIALS
trial_result
· 2016-05-18
Clinical Trial Update: Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo [Phase 3]
Summary
Phase 3 trial comparing ozenoxacin 1% cream to placebo in impetigo assessed efficacy and safety, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferrer Internacional S.A. | Conditions: Impetigo | Phase 3 | Status: COMPLETED | Results posted: 2016-05-18